ESSA Pharma Inc. (EPIX) Social Stream
ESSA PHARMA INC (EPIX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ESSA PHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-03 | 4 | $50 | $22 | $37.2 | $3.31 | 1023.87% |
| 2022-02-07 | 3 | $50 | $22 | $37.8 | $3.31 | 1041.99% |
| 2022-05-11 | 3 | $42 | $20 | $31.8 | $3.31 | 860.73% |
| 2022-05-15 | 3 | $42 | $20 | $30.8 | $3.31 | 830.51% |
| 2022-05-27 | 3 | $45 | $20 | $31.4 | $3.31 | 848.64% |
| 2022-11-14 | 3 | $25 | $20 | $23 | $3.31 | 594.86% |
| 2022-12-13 | 4 | $25 | $20 | $23 | $3.31 | 594.86% |
| 2022-12-14 | 4 | $25 | $17 | $21.2 | $3.31 | 540.48% |
| 2023-05-09 | 4 | $27 | $17 | $21.6 | $3.31 | 552.57% |
| 2023-08-14 | 4 | $27 | $15 | $19.4 | $3.31 | 486.1% |
The Trend in the Analyst Price Target
EPIX's average price target has moved down $18.4 over the prior 18 months.
Over the past 42 weeks, EPIX's average upside potential has been 582.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-31 | 4 | 25 | 20 | 23.0 | 3.60 | 538.89% |
| 2022-12-13 | 4 | 25 | 20 | 23.0 | 3.16 | 627.85% |
| 2022-12-14 | 4 | 25 | 17 | 21.2 | 2.99 | 609.03% |
| 2022-12-19 | 4 | 27 | 17 | 21.6 | 2.55 | 747.06% |
| 2023-08-09 | 4 | 27 | 15 | 19.4 | 2.79 | 595.34% |
EPIX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 36 months, EPIX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- EPIX has a higher upside potential (average analyst target price relative to current price) than 1332.7% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ESSA PHARMA INC's number of analysts covering the stock is greater than 145.73% of them.
- In the context of stocks in the small market cap category, ESSA PHARMA INC's average analyst price target is higher than 990.04% of them.
- ESSA PHARMA INC's variance in analysts' estimates is lower than -748.12% of stocks in the small market cap category.
In the Pharmaceutical Products industry, VKTX, ELDN, and LRMR are the three stocks most similar to ESSA PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EPIX using the data that counts. Try POWR Ratings for free.